Objective: To evaluate the effectiveness of ultraviolet-C (UV-C) disinfection as an adjunct to standard chlorine-based disinfectant terminal room cleaning in reducing transmission of hospital-acquired multidrug-resistant organisms (MDROs) from a prior room occupant.
Design: A retrospective cohort study was conducted to compare rates of MDRO transmission by UV-C status from January 1, 2016, through December 31, 2018.
Setting: Acute-care, single-patient hospital rooms at 6 hospitals within an academic healthcare system in Pennsylvania.
Methods: Transmission of hospital-acquired MDRO infection was assessed in patients subsequently assigned to a single-patient room of a source occupant with carriage of 1 or more MDROs on or during admission. Acquisition of 5 pathogens was compared between exposed patients in rooms with standard-of-care chlorine-based disinfectant terminal cleaning with or without adjunct UV-C disinfection. Logistic regression analysis was used to estimate the adjusted risk of pathogen transfer with adjunctive use of UV-C disinfection.
Results: In total, 33,771 exposed patient admissions were evaluated; the source occupants carried 46,688 unique pathogens. Prior to the 33,771 patient admissions, 5,802 rooms (17.2%) were treated with adjunct UV-C disinfection. After adjustment for covariates, exposed patients in rooms treated with adjunct UV-C were at comparable risk of transfer of any pathogen (odds ratio, 1.06; 95% CI, 0.84-1.32; = .64).
Conclusion: Our analysis does not support the use of UV-C in addition to post-discharge cleaning with chlorine-based disinfectant to lower the risk of prior room occupant pathogen transfer.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726560 | PMC |
http://dx.doi.org/10.1017/ash.2022.254 | DOI Listing |
Mol Biol Rep
December 2024
Department of Biology, Varamin- Pishva Branch, Islamic Azad University, Varamin, 33817-74895, Iran.
Background: Acinetobacter baumannii is a critical pathogen associated with hospital-acquired infections, particularly in burn and intensive care unit (ICU) patients, and is notorious for its high level of antibiotic resistance. This study aims to evaluate the antibacterial potential of silver nanoparticles (AgNPs) synthesized using Acroptilon repens extract as a promising alternative treatment for combating multidrug-resistant A. baumannii.
View Article and Find Full Text PDFMicrobiol Spectr
January 2025
Department of Clinical Laboratory and Biomedical Sciences, Laboratory of Medical Microbiology and Microbiome, Division of Health Sciences, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Euro Surveill
December 2024
Unité de prévention du risque infectieux, Hôpital Saint-Antoine, Assistance Publique - Hôpitaux de Paris, Paris, France.
In 2016-2019, hospital A's haematology ward experienced an outbreak of OXA-48-producing ST-22 strains, with toilets identified as source of transmission. Between 2020 and 2022, 28 strains of OXA-48-producing ST-22 were isolated on other wards. This study aimed to determine whether all OXA-48-producing ST-22 strains belonged to the same clone and to investigate the persistence of this clone using whole genome sequencing.
View Article and Find Full Text PDFJ Hosp Infect
December 2024
Hygiène Hospitalière, Centre Hospitalier Universitaire, Besançon, France; UMR 6249 Chrono-environnement, Université de Franche-Comté, Besançon, France. Electronic address:
Background: Staphylococcus haemolyticus is a clinically relevant coagulase-negative staphylococcus frequently responsible for hospital-acquired infections, especially in premature newborns.
Aim: To describe an outbreak of multidrug-resistant S. haemolyticus in a neonatal department.
Stud Health Technol Inform
November 2024
Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!